Entry |
|
Symbol |
FOS
|
Name |
(RefSeq) proto-oncogene c-Fos
|
KO |
K04379 | proto-oncogene protein c-fos |
|
Organism |
shr Sarcophilus harrisii (Tasmanian devil)
|
Pathway |
shr04620 | Toll-like receptor signaling pathway |
shr04658 | Th1 and Th2 cell differentiation |
shr04660 | T cell receptor signaling pathway |
shr04662 | B cell receptor signaling pathway |
shr04928 | Parathyroid hormone synthesis, secretion and action |
shr04932 | Non-alcoholic fatty liver disease |
shr04935 | Growth hormone synthesis, secretion and action |
shr05166 | Human T-cell leukemia virus 1 infection |
shr05167 | Kaposi sarcoma-associated herpesvirus infection |
shr05170 | Human immunodeficiency virus 1 infection |
shr05207 | Chemical carcinogenesis - receptor activation |
shr05208 | Chemical carcinogenesis - reactive oxygen species |
shr05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
shr05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:shr00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100924435 (FOS)
04668 TNF signaling pathway
100924435 (FOS)
04024 cAMP signaling pathway
100924435 (FOS)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100924435 (FOS)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
100924435 (FOS)
04660 T cell receptor signaling pathway
100924435 (FOS)
04658 Th1 and Th2 cell differentiation
100924435 (FOS)
04659 Th17 cell differentiation
100924435 (FOS)
04657 IL-17 signaling pathway
100924435 (FOS)
04662 B cell receptor signaling pathway
100924435 (FOS)
09152 Endocrine system
04915 Estrogen signaling pathway
100924435 (FOS)
04917 Prolactin signaling pathway
100924435 (FOS)
04921 Oxytocin signaling pathway
100924435 (FOS)
04926 Relaxin signaling pathway
100924435 (FOS)
04935 Growth hormone synthesis, secretion and action
100924435 (FOS)
04928 Parathyroid hormone synthesis, secretion and action
100924435 (FOS)
09156 Nervous system
04725 Cholinergic synapse
100924435 (FOS)
04728 Dopaminergic synapse
100924435 (FOS)
09158 Development and regeneration
04380 Osteoclast differentiation
100924435 (FOS)
09159 Environmental adaptation
04713 Circadian entrainment
100924435 (FOS)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100924435 (FOS)
05207 Chemical carcinogenesis - receptor activation
100924435 (FOS)
05208 Chemical carcinogenesis - reactive oxygen species
100924435 (FOS)
05231 Choline metabolism in cancer
100924435 (FOS)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100924435 (FOS)
09162 Cancer: specific types
05210 Colorectal cancer
100924435 (FOS)
05224 Breast cancer
100924435 (FOS)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100924435 (FOS)
05170 Human immunodeficiency virus 1 infection
100924435 (FOS)
05161 Hepatitis B
100924435 (FOS)
05171 Coronavirus disease - COVID-19
100924435 (FOS)
05162 Measles
100924435 (FOS)
05167 Kaposi sarcoma-associated herpesvirus infection
100924435 (FOS)
09171 Infectious disease: bacterial
05132 Salmonella infection
100924435 (FOS)
05135 Yersinia infection
100924435 (FOS)
05133 Pertussis
100924435 (FOS)
09174 Infectious disease: parasitic
05140 Leishmaniasis
100924435 (FOS)
05142 Chagas disease
100924435 (FOS)
09163 Immune disease
05323 Rheumatoid arthritis
100924435 (FOS)
09165 Substance dependence
05031 Amphetamine addiction
100924435 (FOS)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100924435 (FOS)
05418 Fluid shear stress and atherosclerosis
100924435 (FOS)
09167 Endocrine and metabolic disease
04932 Non-alcoholic fatty liver disease
100924435 (FOS)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
100924435 (FOS)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:shr03000]
100924435 (FOS)
04131 Membrane trafficking [BR:shr04131]
100924435 (FOS)
Transcription factors [BR:shr03000]
Eukaryotic type
Basic leucine zipper (bZIP)
AP-1(-like) components, Fos
100924435 (FOS)
Membrane trafficking [BR:shr04131]
Autophagy
Chaperone mediated autophagy (CMA)
Selective cargos
100924435 (FOS)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
2:complement(305122495..305126139)
|
AA seq |
378 aa
MMYQGFNAEYEASSSRCSSASPAGDSLSYYHSPADSFSSMGSPVNSQDFCTDLSVSSANF
IPTVTAISTSPDLQWLVQPTLISSVAPSQTRVHPYGVSTPSAAVYSRAGIVKTAGGRGQS
IGRRGKVEQLSPEEEEKRRIRRERNKMAAAKCRNRRRELTDTLQAETDQLEDEKSALQTE
IANLLKEKEKLEFILAAHRPACKIPDDLGFPEEITAASLDLTGGLNEATTPESEEAFSLP
LLQEPEPKPSVEPVKNINSLELKAEPFDDFLFPASSRPSGLESAARSVPDMDLAGSFYAA
DWEPLHSSSLGMGVAADLEPLCTPVVTCTPTCTTYTSSFVFTYPEADSFPSCAAAHRKGS
SSNEPSSDSLSSPTLLAL |
NT seq |
1137 nt +upstreamnt +downstreamnt
atgatgtaccaaggattcaatgccgaatacgaagcatcctcctcccgatgcagcagtgct
tccccggctggggacagcctctcttattatcactccccggctgactccttttccagcatg
ggctctcctgtcaactcacaggatttctgcacagatctgtctgtttccagtgccaacttt
ataccgactgtgacggctatatcgacaagcccagacctgcagtggttggttcagcccacc
ctcatctcttctgtagccccatcccagaccagagtccatccttatggagtctctactcct
tcagctgctgtttactctagggctggtattgtgaagactgcaggaggccgagggcaaagc
attggcaggaggggcaaagttgaacagctttccccagaagaagaggagaaaagaaggatc
agaagggaaaggaacaagatggctgcagccaaatgtcgtaacagaaggcgagaactgact
gacacactccaagcggagacagaccaactagaagatgaaaaatctgctttacaaactgag
atagccaatctgctgaaggagaaggaaaagcttgaattcatcctggcagcccatcgacct
gcctgcaagattcctgatgacttgggctttccagaagaaataacagctgcctcccttgac
ctcactggtggtctgaatgaggctacaaccccagaatcagaggaagccttctccttgccc
ctcttgcaggagcctgaacccaaaccctctgtggagccagtcaagaatatcaacagtttg
gagctgaaggctgaaccctttgatgatttcctcttcccagcttcctccaggcccagtggc
ttagaatcggctgcgcggtcagtgcctgacatggacctggctggttccttctatgcagca
gactgggagcctcttcacagcagctccttgggaatgggagtagcagctgacctagagcca
ctgtgcactcctgtagtcacttgcacgcctacctgcaccacctatacatcttccttcgtc
ttcacctacccagaagctgattccttccccagctgtgcagcggctcaccggaagggaagc
agcagcaatgagccctcttctgactcactcagctccccaactctgctggctttgtga |